Candel Therapeutics (CADL) Change in Cash (2020 - 2023)
Historic Change in Cash for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to -$7.6 million.
- Candel Therapeutics' Change in Cash rose 5876.68% to -$7.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.6 million, marking a year-over-year decrease of 17189.61%. This contributed to the annual value of $67.2 million for FY2024, which is 29408.57% up from last year.
- Per Candel Therapeutics' latest filing, its Change in Cash stood at -$7.6 million for Q4 2023, which was up 5876.68% from -$8.9 million recorded in Q3 2023.
- Over the past 5 years, Candel Therapeutics' Change in Cash peaked at $64.1 million during Q3 2021, and registered a low of -$18.4 million during Q4 2022.
- For the 4-year period, Candel Therapeutics' Change in Cash averaged around $1.1 million, with its median value being -$5.7 million (2021).
- Per our database at Business Quant, Candel Therapeutics' Change in Cash skyrocketed by 296405.9% in 2021 and then crashed by 64501.53% in 2023.
- Candel Therapeutics' Change in Cash (Quarter) stood at $16.8 million in 2020, then tumbled by 134.19% to -$5.7 million in 2021, then tumbled by 219.73% to -$18.4 million in 2022, then surged by 58.77% to -$7.6 million in 2023.
- Its last three reported values are -$7.6 million in Q4 2023, -$8.9 million for Q3 2023, and -$7.4 million during Q2 2023.